Data is not available at this time.
Reinsurance Group of America, Incorporated (RGA) operates as a global leader in the reinsurance industry, specializing in life and health reinsurance solutions. The company generates revenue primarily through risk-sharing agreements with insurers, offering products such as longevity reinsurance, disability coverage, and critical illness protection. RGA’s diversified portfolio spans North America, Asia-Pacific, Europe, and other regions, positioning it as a key player in mitigating insurers’ exposure to mortality and morbidity risks. The firm’s deep actuarial expertise and strong underwriting discipline enable it to maintain a competitive edge in a complex, highly regulated market. RGA’s market position is reinforced by long-standing relationships with primary insurers and its ability to structure tailored reinsurance treaties. The company’s focus on innovation, including data analytics and predictive modeling, further enhances its value proposition in an industry increasingly driven by technological advancements.
RGA reported revenue of $21.995 billion for FY 2024, with net income of $717 million, reflecting a net margin of approximately 3.3%. Diluted EPS stood at $10.73, indicating stable earnings per share performance. Operating cash flow was robust at $9.37 billion, underscoring the company’s ability to generate liquidity from core operations. Notably, RGA’s capital expenditures were negligible, highlighting its asset-light business model and operational efficiency.
The company’s earnings power is driven by its underwriting discipline and investment income, with a focus on long-term profitability. RGA’s capital efficiency is evident in its ability to deploy reinsurance capacity effectively across global markets. The firm’s diluted EPS of $10.73 demonstrates its capacity to deliver consistent shareholder returns, supported by a balanced approach to risk management and capital allocation.
RGA maintains a solid balance sheet, with cash and equivalents of $3.326 billion and total debt of $5.042 billion. The company’s financial health is supported by strong operating cash flows, which provide ample liquidity to meet obligations. The debt level is manageable relative to its cash reserves and earnings capacity, reflecting a prudent approach to leverage.
RGA has demonstrated steady growth in its reinsurance portfolio, with a focus on expanding its presence in emerging markets. The company’s dividend policy is shareholder-friendly, with a dividend per share of $3.56, offering a yield that aligns with industry peers. This reflects RGA’s commitment to returning capital to shareholders while maintaining financial flexibility for strategic initiatives.
RGA’s valuation reflects its position as a leading reinsurer, with market expectations centered on its ability to sustain underwriting profitability and manage risks effectively. The company’s P/E ratio and other valuation metrics are likely influenced by its stable earnings and growth prospects in key markets. Investor sentiment is tempered by the inherent volatility of the reinsurance industry.
RGA’s strategic advantages include its global footprint, actuarial expertise, and strong client relationships. The outlook for the company is positive, driven by demand for reinsurance solutions in an aging population and increasing healthcare costs. However, macroeconomic uncertainties and regulatory changes remain key risks. RGA is well-positioned to navigate these challenges through its disciplined underwriting and innovative product offerings.
Company filings, investor presentations
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |